UK markets closed

Jazz Pharmaceuticals plc (JAZZ)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
157.36+0.81 (+0.52%)
As of 02:35PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
3,481,445
3,094,238
2,363,567
2,161,761
1,890,922
Cost of revenue
520,869
440,760
148,917
127,930
121,544
Gross profit
2,960,576
2,653,478
2,214,650
2,033,831
1,769,378
Operating expenses
Research development
565,507
505,748
335,375
299,726
226,616
Selling general and administrative
1,437,430
1,451,683
854,233
736,942
683,530
Total operating expenses
2,640,584
2,483,200
1,449,188
1,391,482
1,111,644
Operating income or loss
319,992
170,278
765,462
642,349
657,734
Interest expense
315,843
278,766
99,707
72,261
77,075
Total other income/expenses net
-89,274
-4,350
-390,660
-115,786
-51,196
Income before tax
-85,125
-112,838
275,095
454,302
529,463
Income tax expense
-46,100
216,116
33,517
-73,154
80,162
Income from continuing operations
-51,872
-329,668
238,616
523,367
447,098
Net income
-51,872
-329,668
238,616
523,367
447,098
Net income available to common shareholders
-51,872
-329,668
238,616
523,367
447,098
Basic EPS
-
-5.52
4.28
9.22
7.45
Diluted EPS
-
-5.52
4.22
9.09
7.30
Basic average shares
-
59,694
55,712
56,749
59,976
Diluted average shares
-
59,694
56,517
57,550
61,221
EBITDA
-
718,411
653,055
896,719
823,269